| Full Name | Kim Hoang Vu |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 325 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003443649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OP61434421 (Washington) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kim Hoang Vu, 325 9th Ave # 359755, Seattle, WA 98104-2499 Ph: (206) 744-9102 | Kim Hoang Vu, 325 9th Ave, Seattle, WA 98104-2420 Ph: (206) 744-4191 |
News Archive
Velcura Therapeutics has announced the development of a custom Affymetrix GeneChip(R) array that aids the development of bone disease therapies by enabling researchers to follow global changes in gene expression during human bone formation.
Delirium is a medical term for "sudden confusion." It is an abrupt, rapid change in mental function and can cause a wide variety of shifts in behavior ranging from aggression or agitation to feeling sleepy and inactive (or even a combination of several behaviors).
Case Western Reserve University (CWRU) School of Medicine has received $7,942,500 million in federal stimulus funds from the Ohio Health Information Partnership (OHIP), the state designated entity for health information exchange development. The funding will position CWRU School of Medicine as a regional extension center (REC) which allows it to help 1,765 health care providers in Lorain, Cuyahoga, Lake, Geauga and Ashtabula counties advance the use of health information technology (HIT) in their practices.
There are probably at least 500 medically useful chemicals awaiting discovery in plant species whose chemical constituents have not yet been evaluated for their potential to cure or treat disease, according to a new analysis by a New York Botanical Garden scientist who has more than 15 years of experience in collecting plants for natural-products discovery programs.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that lead cancer stem cell inhibitor, VS-6063 (defactinib), has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of mesothelioma, a rare form of lung cancer.
› Verified 5 days ago
Claire M Barnett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 E Madison St, Seattle, WA 98122 Phone: 206-328-7722 Fax: 206-720-4657 | |
Dr. Gregory Parada, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8720 14th Ave S, Seattle, WA 98108 Phone: 206-762-3730 Fax: 206-764-5494 | |
Michael S Grabinski, M.D., M.P.H. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 904 7th Ave, 8th Floor, Seattle, WA 98104 Phone: 206-860-4424 Fax: 206-720-7424 | |
Xin Jie Luo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Fauntleroy Way Sw, Seattle, WA 98116 Phone: 206-201-0551 Fax: 206-201-0552 | |
Brooke Elizabeth Parker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11011 Meridian Ave N Ste 201, Seattle, WA 98133 Phone: 206-520-5000 | |
Eunice Mbela Nachinga, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 125 16th Ave E # Csb545, Seattle, WA 98112 Phone: 206-326-3769 | |
Michelle K Xu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1401 Madison St Ste 100, Seattle, WA 98104 Phone: 206-386-6111 Fax: 206-386-6113 |